Pyridoxine for Capecitabine–Induced Hand-Foot Syndrome
This randomized clinical trial compares the incidence and time to onset of grade 2 or higher hand-foot syndrome in patients receiving pyridoxine vs placebo and identifies biomarkers predictive of hand-foot syndrome.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου